Navigation Links
Pesticide combination affects bees' ability to learn
Date:3/28/2013

Two new studies have highlighted a negative impact on bees' ability to learn following exposure to a combination of pesticides commonly used in agriculture. The researchers found that the pesticides, used in the research at levels shown to occur in the wild, could interfere with the learning circuits in the bee's brain. They also found that bees exposed to combined pesticides were slower to learn or completely forgot important associations between floral scent and food rewards.

In the study published today (27th March 2013) in Nature Communications, the University of Dundee's Dr Christopher Connolly and his team investigated the impact on bees' brains of two common pesticides: pesticides used on crops called neonicotinoid pesticides, and another type of pesticide, coumaphos, that is used in honeybee hives to kill the Varroa mite, a parasitic mite that attacks the honey bee.

The intact bees' brains were exposed to pesticides in the lab at levels predicted to occur following exposure in the wild and brain activity was recorded. They found that both types of pesticide target the same area of the bee brain involved in learning, causing a loss of function. If both pesticides were used in combination, the effect was greater.

The study is the first to show that these pesticides have a direct impact on pollinator brain physiology. It was prompted by the work of collaborators Dr Geraldine Wright and Dr Sally Williamson at Newcastle University who found that combinations of these same pesticides affected learning and memory in bees. Their studies established that when bees had been exposed to combinations of these pesticides for 4 days, as many as 30% of honeybees failed to learn or performed poorly in memory tests. Again, the experiments mimicked levels that could be seen in the wild, this time by feeding a sugar solution mixed with appropriate levels of pesticides.

Dr Geraldine Wright said: "Pollinators perform sophisticated behaviours while foraging that require them to learn and remember floral traits associated with food. Disruption in this important function has profound implications for honeybee colony survival, because bees that cannot learn will not be able to find food."

Together the researchers expressed concerns about the use of pesticides that target the same area of the brain of insects and the potential risk of toxicity to non-target insects. Moreover, they said that exposure to different combinations of pesticides that act at this site may increase this risk.

Dr Christopher Connolly said: "Much discussion of the risks posed by the neonicotinoid insecticides has raised important questions of their suitability for use in our environment. However, little consideration has been given to the miticidal pesticides introduced directly into honeybee hives to protect the bees from the Varroa mite. We find that both have negative impact on honeybee brain function."

"Together, these studies highlight potential dangers to pollinators of continued exposure to pesticides that target the insect nervous system and the importance of identifying combinations of pesticides that could profoundly impact pollinator survival."


'/>"/>

Contact: Rob Dawson
Rob.Dawson@bbsrc.ac.uk
01-793-413-204
Biotechnology and Biological Sciences Research Council
Source:Eurekalert

Related biology news :

1. New approaches for controlling pesticide exposure in children
2. Pesticide application as potential source of noroviruses in fresh food supply chains
3. Prenatal exposure to pesticide DDT linked to adult high blood pressure
4. Scientists take objective look at terms least toxic pesticides applied as last resort
5. Combined pesticide exposure affects bumblebee colony success
6. Air in expectant moms homes contains pesticides, border study finds
7. Commonly used pesticide turns honey bees into picky eaters
8. Effect of chronic exposure to chemicals used as weapons, pesticides under study
9. Novel combination therapy shuts down escape route, killing glioblastoma tumor cells
10. Experimental drug combination selectively destroys lymphoma cells
11. FASEB SRC announces conference registration open for: Genetic Recombination & Genome Rearrangements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... CENTRE, N.Y. , March 27, 2017 /PRNewswire-USNewswire/ ... Healthcare Information and Management Systems Society (HIMSS) Analytics ... Outpatient EMR Adoption Model sm . In addition, ... 12% of U.S. hospitals using an electronic medical ... CHS for its high level of EMR usage ...
(Date:3/23/2017)... 23, 2017 Research and Markets has announced ... & Trends - Industry Forecast to 2025" report to their ... The ... CAGR of around 8.8% over the next decade to reach approximately ... the market estimates and forecasts for all the given segments on ...
(Date:3/20/2017)... , March 20, 2017 At this year,s ... -based biometrics manufacturer DERMALOG. The Chancellor came to the DERMALOG stand ... is this year,s CeBIT partner country. At the largest German biometrics ... in use: fingerprint, face and iris recognition as well as DERMALOG´s multi-biometrics ... ...
Breaking Biology News(10 mins):
(Date:5/18/2017)... ... 2017 , ... Many complicated neurological disorders appear to have ... while men are at greater risk for Parkinson’s disease. Understanding some of the ... of a research program at Worcester Polytechnic Institute (WPI) funded by a new ...
(Date:5/16/2017)... , ... May 16, 2017 , ... ... and cancer diagnostics, has released its ClearID Lung Cancer blood test. Leveraging a ... cancer, this new test is designed to quickly and accurately identify tumor-related genetic ...
(Date:5/15/2017)... ... May 15, 2017 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it has signed an agreement ... support preclinical and clinical development of TA-46, a novel protein addressing achondroplasia, which ...
(Date:5/12/2017)... , May 12, 2017  Eli Lilly and Company ... galcanezumab, an investigational treatment for the prevention of ... in three Phase 3 studies (EVOLVE-1, EVOLVE-2 and ... of monthly migraine headache days compared to placebo ... robust results from these three studies bring us ...
Breaking Biology Technology: